NasdaqGS - Nasdaq Real Time Price
USD
Cullinan Therapeutics, Inc. (CGEM)
21.86
+1.01
(+4.87%)
As of 1:35:00 PM EDT. Market Open.
Trade CGEM on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreLoading chart for CGEM
- Previous Close
20.84 - Open
21.58 - Bid 15.77 x 200
- Ask 27.64 x 200
- Day's Range
21.22 - 21.95 - 52 Week Range
5.68 - 21.95 - Volume
233,111 - Avg. Volume
963,093 - Market Cap (intraday)
1.406B - Beta (5Y Monthly) -0.02
- PE Ratio (TTM)
-- - EPS (TTM)
-3.11 - Earnings Date (est.) Nov 5, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
32.36
Recent News
View More
Performance Overview
Trailing total returns as of 8/19/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
CGEM
111.16%
S&P 500 (^GSPC)
12.67%
1-Year Return
CGEM
188.32%
S&P 500 (^GSPC)
20.30%
3-Year Return
CGEM
108.54%
S&P 500 (^GSPC)
76.51%
5-Year Return
CGEM
17.53%
S&P 500 (^GSPC)
75.07%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
As of 8/18/2026
-
Market Cap
1.34B
-
Enterprise Value
1.01B
-
Trailing P/E
--
-
Forward P/E
--
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
--
-
Price/Book (mrq)
4.17
-
Enterprise Value/Revenue
--
-
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-31.36%
-
Return on Equity (ttm)
-50.30%
-
Revenue (ttm)
--
-
Net Income Avi to Common (ttm)
-208.34M
-
Diluted EPS (ttm)
-3.11
Balance Sheet and Cash Flow
-
Total Cash (mrq)
334.54M
-
Total Debt/Equity (mrq)
0.64%
-
Levered Free Cash Flow (ttm)
-89.23M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Mkt Cap
undefined
-
Industry
-
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
Research Reports
View More-
Daily – Vickers Top Buyers & Sellers for 06/24/2022
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
-
Daily – Vickers Top Buyers & Sellers for 05/17/2022
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
-
Daily – Vickers Top Buyers & Sellers for 04/07/2022
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
